Assignee
XILIO DEV INC
US·8 granted patents·14 pending applications·15 citations·filing 2019–2025
Top patents by PatentIndex Score
22 records- 0195US11053294B2Masked cytokine polypeptidesXILIO DEV INC·Filed 2020·Granted Jul 6, 2021·13 cites·15 claims
- 0292US11866476B2Masked IL-2-Fc fusion polypeptidesXILIO DEV INC·Filed 2022·Granted Jan 9, 2024·1 cites·10 claims
- 0390US11718655B2Masked interleukin-12 polypeptidesXILIO DEV INC·Filed 2022·Granted Aug 8, 2023·1 cites·9 claims
- 0475US11827686B2Masked cytokine polypeptidesXILIO DEV INC·Filed 2021·Granted Nov 28, 2023·0 cites·9 claims
- 0575US11827685B2Masked cytokine polypeptidesXILIO DEV INC·Filed 2021·Granted Nov 28, 2023·0 cites·18 claims
- 0674US2025289889A1Activatable masked anti-ctla4 binding proteinsXILIO DEV INC·Filed 2025·Application pending·0 cites
- 0774US2022002370A1Masked cytokine polypeptidesXILIO DEV INC·Filed 2019·Application pending·0 cites
- 0872US12435142B2Anti-CTLA4 antibodies and methods of use thereofXILIO DEV INC·Filed 2019·Granted Oct 7, 2025·0 cites·16 claims
- 0970US12384845B2Activatable masked anti-CTLA4 binding proteinsXILIO DEV INC·Filed 2019·Granted Aug 12, 2025·0 cites·14 claims
- 1064US2026008831A1Masked il-2 cytokines and methods of use thereofXILIO DEV INC·Filed 2025·Application pending·0 cites
- 1162US2025101075A1Masked il-2 cytokines and methods of use thereofXILIO DEV INC·Filed 2024·Application pending·0 cites
- 1261US2025092109A1Vhh masked cytokines and methods of use thereofXILIO DEV INC·Filed 2024·Application pending·0 cites
- 1358US2022306743A1Combination of ctla4 and pd1/pdl1 antibodies for treating cancerXILIO DEV INC·Filed 2022·Application pending·0 cites
- 1458US2022340662A1Combination of masked ctla4 and pd1/pdl1 antibodies for treating cancerXILIO DEV INC·Filed 2022·Application pending·0 cites
- 1557US2023365641A1Targeted cytokines and methods of use thereofXILIO DEV INC·Filed 2023·Application pending·0 cites
- 1656US2024141007A1Engineered cleavable carriers and methods of use thereofXILIO DEV INC·Filed 2023·Application pending·0 cites
- 1754US12280120B2Tumor-specific cleavable linkersXILIO DEV INC·Filed 2021·Granted Apr 22, 2025·0 cites·11 claims
- 1849US2023331799A1Masked il-15 cytokines and their cleavage productsXILIO DEV INC·Filed 2021·Application pending·0 cites
- 1949US2023159603A1Masked il-12 cytokines and their cleavage productsXILIO DEV INC·Filed 2021·Application pending·0 cites
- 2049US2023151072A1Masked il-2 cytokines and their cleavage productsXILIO DEV INC·Filed 2021·Application pending·0 cites
- 2148US2025250314A1Masked il-2 cytokines and methods of use thereofXILIO DEV INC·Filed 2025·Application pending·0 cites
- 2248US2023144608A1Cleavable linkersXILIO DEV INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →